GSK Announces Regulatory Submission Of Its Type 2 Diabetes Drug Albigultide

Drugs

GlaxoSmithKline has announced a regulatory submission to the U.S. Food and Drug Administration for its type 2 diabetes drug called albigultide.

Read more

Posted in Drugs